Evaluation of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing
The goal of this experimental interventional study is to learn if the psychological treatment Radically Open Dialectical Behavior Therapy (RO-DBT), is feasible to conduct and provide positive effects for adolescents with eating disorders and emotional overcontrol. Participants will be those at risk for developing sever
| Condition(s) | Eating Disorders, Anorexia Nervosa, Anorexia Nervosa, Atypical, Feeding and Eating Disorders |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this experimental interventional study is to learn if the psychological treatment Radically Open Dialectical Behavior Therapy (RO-DBT), is feasible to conduct and provide positive effects for adolescents with eating disorders and emotional overcontrol. Participants will be those at risk for developing severe and enduring eating disorder symptoms, as they have not responded fully to previous treatment attempts. Primary outcomes are feasibility and changes in eating disorder symptoms. Secondary outcomes are changes in unhelpful behaviors and experiences related to emotional overcontrol; including psychological inflexibility, suppression of emotions, and experience of loneliness. The participants will undergo the treatment with RO-DBT, which include an approximately 22 week long t |
| Who can participate | Inclusion Criteria: * Being 14-19 years old * Primarily restrictive eating disorder symptoms that remain despite at least one previous treatment attempt. * Problems related to maladaptive overcontrol * Written informed consent (for minors, this includes consent from all caregivers and the minors themselves). Exclusion criteria: * Eating disorders symptoms in need of emergency care * High risk for suicide * An inability to respond to the questionnaires or participate in the skills class, e.g., due to lack of knowledge in Swedish. |
| Ages | 14 Years to 19 Years |
| Sex | All |
| Lead sponsor | Uppsala University Hospital |
| Locations | Uppsala, Sweden |
| Start date | 2025-02 |
| NCT ID | NCT06792071 |
| Official listing | https://clinicaltrials.gov/study/NCT06792071 |